Form 4: NEOGEN Director Avi Pelossof Acquires Shares & Options

NEOGEN Director Avi Pelossof reported the acquisition of 19,386 shares of common stock and 49,929 derivative securities, effective October 24, 2025.

Summary

• Avi Pelossof, a Director of NEOGEN CORP (NEOG), acquired 19,386 shares of common stock.
• The common stock was acquired at a price of $6.19 per share.
• Pelossof also acquired 49,929 derivative securities, specifically a 'Right to Buy' common stock, with an exercise price of $6.19.
• Both transactions occurred on October 24, 2025.
• The acquired options and Restricted Stock Units (RSUs) are scheduled to vest in equal annual installments over the first three anniversary dates of the grants.
• The derivative securities have an expiration date of October 24, 2035.

Sentiment

Score: 7

Explanation: The acquisition of shares and derivative securities by a director is generally viewed as a positive signal, indicating management's confidence in the company's future performance and aligning their interests with shareholders.

Positives

• The acquisition of common stock and derivative securities by a director signals confidence in the company's future prospects.
• Increased insider ownership aligns management's interests more closely with those of shareholders.

Future Outlook

The acquired options and RSUs are structured to vest in equal annual installments over the first three anniversary dates of the grants, indicating a long-term incentive structure for the director.

Industry Context

This insider transaction reflects a director's individual investment decision and does not directly provide broader industry trends or competitive analysis. However, insider buying can be a positive signal within the industry, suggesting confidence in the company's position.

Related Party Transactions

• Avi Pelossof, a Director of NEOGEN CORP, acquired 19,386 shares of common stock and 49,929 derivative securities from the issuer. This constitutes a related party transaction as it involves a company insider.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.

Next Steps

• Vesting of options and RSUs in equal annual installments on the first three anniversary dates of the grants.

Key Dates

Recommendation

The direct acquisition of common stock and derivative securities by a director, particularly at a specified price, suggests strong insider confidence in NEOGEN's valuation and future prospects. This increased alignment of interests between management and shareholders typically serves as a positive signal for investors, warranting a 'buy' recommendation based on this filing.

Keywords

NEOGEN, NEOG, Insider Trading, Form 4, Director Acquisition, Common Stock, Derivative Securities, Stock Options, Restricted Stock Units